| __timestamp | Corcept Therapeutics Incorporated | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 15635076 |
| Thursday, January 1, 2015 | 15419000 | 23943601 |
| Friday, January 1, 2016 | 23844000 | 23689111 |
| Sunday, January 1, 2017 | 40376000 | 41006114 |
| Monday, January 1, 2018 | 75247000 | 51379106 |
| Tuesday, January 1, 2019 | 89017000 | 32705593 |
| Wednesday, January 1, 2020 | 114764000 | 53274000 |
| Friday, January 1, 2021 | 113864000 | 85352000 |
| Saturday, January 1, 2022 | 130991000 | 51999000 |
| Sunday, January 1, 2023 | 184353000 | 59471000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Corcept Therapeutics Incorporated and Summit Therapeutics Inc. have demonstrated contrasting strategies in their R&D investments.
Corcept Therapeutics has shown a remarkable increase in its R&D budget, growing by over 900% from 2014 to 2023. This consistent rise reflects the company's strategic focus on expanding its therapeutic offerings, particularly in the field of endocrinology.
In contrast, Summit Therapeutics has maintained a more balanced R&D expenditure, with a peak in 2021. Despite fluctuations, their investment strategy underscores a commitment to sustainable growth and innovation in antibiotic development.
These trends highlight the diverse approaches within the biotech sector, where strategic R&D investments can significantly influence a company's trajectory.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
R&D Insights: How Neurocrine Biosciences, Inc. and Corcept Therapeutics Incorporated Allocate Funds
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Veracyte, Inc.